3'-Amino-2'-hydroxybiphenyl-3-carboxylic Acid>98.0%(HPLC)(T)200mg

(4-Methyl-2-thioxo-2,3-dihydro-thiazol-5-yl)-acetic acid, 97.0%, 5g

N-Boc-2-Amino-5-bromopyrimidine, 95.0%, 250mg

2-Bromo-1-methoxy-4-methyl-3-nitrobenzene, 95.0%, 100mg

N-(3-(3-Bromopyrazolo[1,5-a]pyrimidin-7-yl)phenyl)-3-(trifluoromethyl)benzamide, 95.0%, 5g

Phenanthrene-9,10-diamine, 95.0%, 5g

2,2'-(2,5-Dimethoxy-1,4-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 98%, 10g

2-bromo-6-methoxy-4-[(propylamino)methyl]phenol hydrochloride, 95.0%, 10g

2-(4-Cyanophenyl)acetic acid, 97.0%, 25g

6-CHLORO-7-METHYLIMIDAZO[1,2-B]PYRIDAZINE, 95.0%, 100mg

3-(4-Bromo-1h-pyrazol-1-yl)pyridine, 98+%, 5g

(4-Bromophenyl)phosphonic Acid>98.0%(HPLC)200mg

GC capillary column ROTI®Cap-1, 50 m, 0.25 mm, 0.25 µm, 1 Piece(s)